ECSP066618A - METHOD FOR IMPROVING THE EFFECTIVENESS OF RADIOOTULATED THERAPEUTIC DRUGS - Google Patents
METHOD FOR IMPROVING THE EFFECTIVENESS OF RADIOOTULATED THERAPEUTIC DRUGSInfo
- Publication number
- ECSP066618A ECSP066618A EC2006006618A ECSP066618A ECSP066618A EC SP066618 A ECSP066618 A EC SP066618A EC 2006006618 A EC2006006618 A EC 2006006618A EC SP066618 A ECSP066618 A EC SP066618A EC SP066618 A ECSP066618 A EC SP066618A
- Authority
- EC
- Ecuador
- Prior art keywords
- improving
- radiootulated
- effectiveness
- drug
- therapeutic drugs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1027—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
- A61K51/1069—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from blood cells, e.g. the cancer being a myeloma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Optics & Photonics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Se dan a conocer drogas radiorotuladas y métodos para mejorar su eficacia mediante el uso de un radiosensibilizador tal que el radiosensibilizador tanto forma parte de la droga radiorotulada mediante el acople directo del radiosensibilizador a la droga radiorotulada como produciendo una mezcla de la droga radiorotulada y un análogo de la droga con el radiosensibilizador acoplado a la droga en lugar del radiorótulo.Radio-labeled drugs and methods for improving their efficacy are disclosed through the use of a radiosensitizer such that the radiosensitizer is both part of the radio-labeled drug by direct coupling of the radiosensitizer to the radio-labeled drug and producing a mixture of the radio-labeled drug and an analogue. of the drug with the radiosensitizer coupled to the drug instead of the radiograph.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52847303P | 2003-12-11 | 2003-12-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP066618A true ECSP066618A (en) | 2006-10-25 |
Family
ID=34676848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2006006618A ECSP066618A (en) | 2003-12-11 | 2006-06-08 | METHOD FOR IMPROVING THE EFFECTIVENESS OF RADIOOTULATED THERAPEUTIC DRUGS |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1691838A2 (en) |
| JP (1) | JP2007528874A (en) |
| KR (1) | KR20060118542A (en) |
| CN (1) | CN101031319A (en) |
| AU (1) | AU2004296621A1 (en) |
| BR (1) | BRPI0417517A (en) |
| CA (1) | CA2546057A1 (en) |
| CR (1) | CR8439A (en) |
| EC (1) | ECSP066618A (en) |
| IL (1) | IL175674A0 (en) |
| MX (1) | MXPA06006683A (en) |
| NO (1) | NO20063207L (en) |
| RU (1) | RU2006124510A (en) |
| WO (1) | WO2005056058A2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI568453B (en) * | 2011-11-22 | 2017-02-01 | 原創生醫股份有限公司 | A drug carrier with chelating complex micelles and the application thereof |
| CN106975078B (en) * | 2017-03-31 | 2020-11-10 | 国家纳米科学中心 | Application of nano material containing gadolinium polytungstate as sensitizer |
| WO2024013272A1 (en) * | 2022-07-13 | 2024-01-18 | Universite De Montpellier | Combined therapy with nanoparticles and radiopharmaceuticals |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR022404A1 (en) * | 1999-01-25 | 2002-09-04 | Photogen Inc | METHOD AND AGENTS FOR IMPROVED RADIATION THERAPY |
| AU2001249608A1 (en) * | 2000-03-28 | 2001-10-08 | Beth Israel Deaconess Medical Center | Bladder cancer-specific peptides for diagnosis and therapy |
| NZ545176A (en) * | 2001-01-29 | 2008-05-30 | Biogen Idec Inc | Modified antibodies reactive with CD20 and methods of use |
| AU2003259835A1 (en) * | 2002-08-15 | 2004-03-03 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to trail receptors |
-
2004
- 2004-12-13 KR KR1020067011322A patent/KR20060118542A/en not_active Application Discontinuation
- 2004-12-13 AU AU2004296621A patent/AU2004296621A1/en not_active Abandoned
- 2004-12-13 WO PCT/IB2004/004428 patent/WO2005056058A2/en active Search and Examination
- 2004-12-13 MX MXPA06006683A patent/MXPA06006683A/en unknown
- 2004-12-13 RU RU2006124510/15A patent/RU2006124510A/en not_active Application Discontinuation
- 2004-12-13 EP EP04817629A patent/EP1691838A2/en not_active Withdrawn
- 2004-12-13 CA CA002546057A patent/CA2546057A1/en not_active Abandoned
- 2004-12-13 BR BRPI0417517-4A patent/BRPI0417517A/en not_active IP Right Cessation
- 2004-12-13 CN CNA2004800369951A patent/CN101031319A/en active Pending
- 2004-12-13 JP JP2006543664A patent/JP2007528874A/en not_active Withdrawn
-
2006
- 2006-05-16 IL IL175674A patent/IL175674A0/en unknown
- 2006-06-07 CR CR8439A patent/CR8439A/en unknown
- 2006-06-08 EC EC2006006618A patent/ECSP066618A/en unknown
- 2006-07-10 NO NO20063207A patent/NO20063207L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL175674A0 (en) | 2006-09-05 |
| MXPA06006683A (en) | 2006-08-11 |
| CR8439A (en) | 2006-12-07 |
| CA2546057A1 (en) | 2005-06-23 |
| RU2006124510A (en) | 2008-01-20 |
| WO2005056058A2 (en) | 2005-06-23 |
| WO2005056058A3 (en) | 2006-04-13 |
| KR20060118542A (en) | 2006-11-23 |
| AU2004296621A1 (en) | 2005-06-23 |
| NO20063207L (en) | 2006-07-10 |
| CN101031319A (en) | 2007-09-05 |
| EP1691838A2 (en) | 2006-08-23 |
| JP2007528874A (en) | 2007-10-18 |
| BRPI0417517A (en) | 2007-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR049985A1 (en) | COMBINATION TREATMENT FOR NON-HEMATOLOGICAL MALIGNAL DISEASES | |
| ECSP099178A (en) | METHOD OF TREATMENT OF THE ICTUS WITH A THROMBOLITIC | |
| MY157661A (en) | Bendamustine pharmaceutical compositions | |
| CO6361942A2 (en) | COMBINATION THERAPY WITH PEPTIDIC EPOXYCETONES | |
| UY28757A1 (en) | SUBSTITUTED PIRAZOLINE COMPOUNDS, THEIR PREPARATION AND THEIR USE AS MEDICATIONS | |
| UY28860A1 (en) | PROCEDURE FOR THE TREATMENT OF PREMENSTRUAL DISORDERS AND OTHER FEMALE SEXUAL DISORDERS | |
| PA8606201A1 (en) | PIRROLO DERIVATIVES [3,4-c) PIRAZOL ASSETS AS QUINASE INHIBITORS, PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM | |
| AR054566A1 (en) | TREATMENT OF THE TUMORS THAT EXPRESS THE HER | |
| CR8380A (en) | METHODS FOR PREPARING AND USING NEW DEVELOPMENTS OF MOTHER CELLS AND THEIR ASSEMBLIES | |
| UY26456A1 (en) | COMPOUNDS THAT FIX THE G-QUADRUPLEX STRUCTURE OF TELOMERES, TRIAZINS FOR THE APPLICATION OF SUCH COMPOUNDS, THE USE OF SUCH COMPOUNDS AS PHARMACEUTICAL PRODUCTS AND INCLUDING THERAPEUTICAL ASSOCIATIONS. | |
| CL2013000063A1 (en) | A method of treating a subject comprising administering optionally deuterated n-ethyl-n-phenyl1,2-dihydroxy-4-hodroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, for the treatment of a disease autoimmune; a mixture thereof; Pharmaceutical composition and its preparation process. | |
| NO2012015I2 (en) | Dapoxetine | |
| ATE432279T1 (en) | TRICYCLIC DELTA OPIOID MODULATORS | |
| PA8654601A1 (en) | CYTOTOXIC AGENTS UNDERSTANDING NEW TAXANS | |
| DK1781277T3 (en) | Combination composition comprising Ibuprofen and Paracetamol | |
| UA94036C2 (en) | Bendamustine pharmaceutical compositions for lyophilisation | |
| AR060019A1 (en) | PHARMACEUTICAL COMPOSITION, PRODUCT AND TREATMENT METHOD FOR A COGNITIVE DISORDER AND USES OF AN ACETILCOLINESTERASE INHIBITOR AND A 5- HT6 ANTAGONIST IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A COGNITIVE DISORDER | |
| CR7575A (en) | USE OF DOCETAXEL / DOXORRUBICIN / CYCLOPHOSPHAMIDE IN THE ADJUSING THERAPY OF CANCER OF BREAST AND OVARY | |
| MX2008008413A (en) | Pharmaceutical composition for the treatment of nail diseases. | |
| BR0209645A (en) | Oxazole and furopyrimidines and their use as medicines | |
| AR052152A1 (en) | PHARMACEUTICAL PRODUCT FOR THE PREVENTIVE AND THERAPEUTIC TREATMENT OF SUENO DISORDERS | |
| ECSP066618A (en) | METHOD FOR IMPROVING THE EFFECTIVENESS OF RADIOOTULATED THERAPEUTIC DRUGS | |
| NO20044498L (en) | Combination therapy for the treatment of cancer | |
| AR065528A1 (en) | DOSAGE FORM INCLUDING 6- (3- COCLOBUTIL -2,3,4,5- TETRAHIDRO -1H - BENZO (D) AZEPIN -7-ILOXI) -N - METHYL-NICOTINAMIDE, METHOD TO PRODUCE IT, ITS USE TO PREPARE A MEDICATION AND SOLUTION OR SUSPENSION THAT UNDERSTANDS THEM | |
| AR029666A1 (en) | USE OF (+) -ALFA- (2,3-DIMETOXIFENIL) -1- [2- (4-FLUOROPHENYL) ETHYL] -4-PIPERIDINMETHANOL OR ITS DRUG FOR THE MANUFACTURE OF A MEDICINAL PRODUCT IN THE TREATMENT OF SYMPTOMS OF DEMENTIA AND OF PSYCHOSIS INDUCED BY DOPAMINE |